Therapeutic levels and outcome variability associated with generic medicines
- At: 2011 FIP Congress in Hyderabad (India)
- Type: Presentation
- By: ABD EL HAKIM, Mohamed (World Health Organization (WHO), Cairo, Egypt)
The proper dose for optimal therapeutic effect of medicines is often determined by the pharmaceutical manufacturer of the originator (brand name) product. Studies of pharmacokinetics, pharmacodynamics, and patient outcomes are all determined based on the original product, excipients, and dosage formulation. When a generic medicine is created only.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.